Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 3
1994 1
2001 2
2002 2
2004 2
2005 6
2006 10
2007 4
2008 7
2009 7
2010 10
2011 4
2012 9
2013 10
2014 7
2015 2
2016 5
2017 9
2018 10
2019 13
2020 9
2021 3
2022 6
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Electrophysiological and molecular changes following neuroprotective placental protein administration on tinnitus-induced rats.
Farhadi M, Gorji A, Mirsalehi M, Poletaev AB, Asadpour A, Mahboudi F, Jafarian M, Farrahizadeh M, Akbarnejad Z, Mahmoudian S. Farhadi M, et al. Among authors: mahboudi f. Laryngoscope Investig Otolaryngol. 2023 Oct 3;8(5):1410-1420. doi: 10.1002/lio2.1156. eCollection 2023 Oct. Laryngoscope Investig Otolaryngol. 2023. PMID: 37899856 Free PMC article.
The human neuroprotective placental protein composition suppressing tinnitus and restoring auditory brainstem response in a rodent model of sodium salicylate-induced ototoxicity.
Farhadi M, Gorji A, Mirsalehi M, Müller M, Poletaev AB, Mahboudi F, Asadpour A, Ebrahimi M, Beiranvand M, Khaftari MD, Akbarnejad Z, Mahmoudian S. Farhadi M, et al. Among authors: mahboudi f. Heliyon. 2023 Aug 11;9(8):e19052. doi: 10.1016/j.heliyon.2023.e19052. eCollection 2023 Aug. Heliyon. 2023. PMID: 37636471 Free PMC article.
Development of polyclonal heavy chain antibodies targeting programmed death ligand-1.
Oghalaie A, Shoari A, Kazemi-Lomedasht F, Rahimi-Jamnani F, Mahboudi F, Ghaderi H, Hosseininejad-Chafi M, Moazzami R, Ashja Ardalan A, Piri-Gavgani S, Shahbazzadeh D, Behdani M. Oghalaie A, et al. Among authors: mahboudi f. Vet Res Forum. 2023;14(6):323-328. doi: 10.30466/vrf.2022.553274.3461. Epub 2023 Jun 15. Vet Res Forum. 2023. PMID: 37383651 Free PMC article.
Development and characterization of single domain monoclonal antibody against programmed cell death ligand-1; as a cancer inhibitor candidate.
Oghalaie A, Mahboudi F, Rahimi-Jamnani F, Piri-Gavgani S, Kazemi-Lomedasht F, Hassanzadeh Eskafi A, Shahbazzadeh D, Adeli A, Talebkhan Y, Behdani M. Oghalaie A, et al. Among authors: mahboudi f. Iran J Basic Med Sci. 2022 Mar;25(3):313-319. doi: 10.22038/IJBMS.2022.62522.13834. Iran J Basic Med Sci. 2022. PMID: 35656179 Free PMC article.
134 results